Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105742 · ClinicalTrials.gov registry record · Phase 2
Audiology Visits After Screening for Hearing Loss: An RCT
A Phase 2 study of Hard of Hearing, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,400
- Enrollment target
- 1
- Study location
NCT00105742: Completed Phase 2 study of Hard of Hearing, sponsored by US Department of Veterans Affairs.
NCT00105742 is a Phase 2 study of Hard of Hearing that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,400 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (953% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105742, a Phase 2 study of Hard of Hearing, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,400 participants
- Enrollment target
- 1
- Study location
Study Summary
Hearing impairment is one of the most common disabilities in veterans. The decreased ability to communicate is troubling in itself, but the strong association of hearing loss with functional decline and depression adds further to the burden on the hearing-impaired. Although hearing amplification improves quality of life, hearing evaluations are offered infrequently to older patients. Only 25 percent of patients with aidable hearing loss receive treatment. Up to 30 percent of patients who receive hearing aids do not use them. We contend that an effective formal screening program should identify hearing-impaired patients who are motivated to seek evaluation and who derive benefit from treatment.
Conditions Studied
Interventions
- PROCEDURE Diagnosis
Study Locations (1)
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
What the finished NCT00105742 record still lists
NCT00105742 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (953% higher).
The record links to 1 condition, with Hard of Hearing appearing as the primary indexed condition, and to 1 intervention - of which Diagnosis is the first listed.
NCT00105742 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00105742 about?
NCT00105742 is a clinical study titled "Audiology Visits After Screening for Hearing Loss: An RCT". Hearing impairment is one of the most common disabilities in veterans. The decreased ability to communicate is troubling in itself, but the strong association of hearing loss with functional decline and depression adds further to the burden on the hearing-impaired. Although hearing amplification imp...
What is the current status of trial NCT00105742?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,400 participants. Estimated completion is 2005-06.
What conditions does trial NCT00105742 study?
This clinical trial studies the following conditions: Hard of Hearing.
What interventions are being tested in trial NCT00105742?
The interventions under investigation include: Diagnosis (PROCEDURE).
Who is sponsoring clinical trial NCT00105742?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00105742 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00105742's enrollment target sits among peer trials
1,400 12th of 2000 higher than 1,988 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry